Physician

Olufemi A Lawal, M.D

According to 2025 Medicare claims, Olufemi Lawal, M.D (NPI: 1891056099) practices critical care (intensivists) in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is PULMONARY SERVICES OF NORTH TEXAS PLLC (NPI: 1275934747; TIN: 471791717) and primary practice location at 76301-5602. Lawal is affiliated with the Caravan Health ACO 43 LLC (ACO ID: A4974) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Lawal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 727 traditional Medicare patients, billed 19,209 HCPCS/CPT codes, and received $640,512 in Medicare payments. The top billing code was 99291 (Critical care, first 30-74 minutes). Part D data shows 2,117 prescription claims across 381 beneficiaries totaling $1,947,584 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,858 claims. Open Payments data shows 85 records totaling $2,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $49,548 to $640,512. Similarly, Part D prescription costs have risen steadily, from $87,815 to $1,947,584. For DME billing, reported payments rose steadily, from $5,030 to $190,940.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	307	778	$49,548
2016	480	1,634	$98,410
2017	577	1,716	$99,998
2018	651	1,830	$127,242
2019	667	4,252	$260,868
2020	696	7,546	$351,978
2021	661	5,312	$299,651
2022	711	6,478	$334,682
2023	714	10,817	$387,506
2024	727	19,209	$640,512

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	106	375	$87,815
2016	238	1,491	$554,889
2017	273	2,035	$891,578
2018	289	2,047	$951,500
2019	175	778	$307,081
2020	182	966	$625,462
2021	209	1,129	$711,182
2022	261	1,408	$1,061,606
2023	298	1,551	$1,985,870
2024	381	2,117	$1,947,584

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	16	74	$9,860
2016	326	1,210	$111,220
2017	613	2,636	$211,570
2018	710	3,284	$284,521
2019	365	1,387	$126,586
2020	318	1,373	$185,929
2021	419	1,915	$255,185
2022	531	2,443	$339,274
2023	602	3,029	$380,982
2024	595	2,858	$372,457

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99291	Critical care, first 30-74 minutes	156	385	$159
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	406	686	$89
94729	Test to examine how well the lungs exchange gases	194	194	$42
94726	Test to determine lung volumes using sensors	190	190	$40
94618	Test for exercise-induced lung stress	193	193	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	447	17,550	$369,588
Ofev	Nintedanib Esylate	26	780	$338,371
Opsumit	Macitentan	22	660	$269,566
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	238	8,461	$176,029
Fasenra Pen	Benralizumab	18	952	$117,787

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	29	182	$152,715
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	12	67	$68,224
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	90	712	$52,688
E0483	High frequency chest wall oscillation system, with full anterior and/or posterior thoracic region receiving simultaneous external oscillation, includes all accessories and supplies, each	Y	N/R	28	$24,547
J7605	Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms	N	31	148	$10,792

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	85	$2,545	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Olufemi A. Lawal, M.D?

Tedicare shows public-source Medicare data for Olufemi A. Lawal, M.D (NPI 1891056099), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Olufemi A. Lawal, M.D have ACO affiliation data?

Olufemi A. Lawal, M.D is shown with ACO affiliation data for Caravan Health ACO 43 LLC (MSSP, ACO ID A4974) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Olufemi A. Lawal, M.D?

Olufemi A. Lawal, M.D is linked to PULMONARY SERVICES OF NORTH TEXAS PLLC (billing NPI 1275934747) in the available physician profile data.

Does Olufemi A. Lawal, M.D have Open Payments data?

Olufemi A. Lawal, M.D has 85 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.